Using whole-exome (WES) and matched RNA sequencing from TNBC patient samples combined with clinical data, we analyze the genomic and transcriptomic profiles linked to TTN mutations and their impact on the tumor microenvironment. The gene discussed is TTN; the disease is neoplasm.